Potential side effects to be aware of include: Bruising or tenderness where the IV catheter is placed
As we will discuss in the clinical evidence section, the story becomes more complicated when you move from animal models to human trials
Further, we can assume that the neuromuscular junction function is a needed precondition that BPC 157 therapy (effective in rat injury, given intraperitoneally or in drinking water or topically, at the site of injury) induces the healing of the transected muscle [71], crushed muscle [72], denervated muscle [73], and myotendinous junction [74]
The business itself is amazing
Some of those claims have genuine preclinical backing
These investigations focus on laboratory-based analysis of peptide structure, molecular stability, and pathway-associated signaling markers evaluated within non-clinical research frameworks